Drug delivery strategies to enhance the permeability of the blood–brain barrier for treatment of glioma

F Zhang, CL Xu, CM Liu - Drug Design, Development and Therapy, 2015 - Taylor & Francis
Gliomas are amongst the most insidious and destructive types of brain cancer and are
associated with a poor prognosis, frequent recurrences, and extremely high lethality despite …

Contemporary mouse models in glioma research

WH Hicks, CE Bird, JI Traylor, DD Shi, TY El Ahmadieh… - Cells, 2021 - mdpi.com
Despite advances in understanding of the molecular pathogenesis of glioma, outcomes
remain dismal. Developing successful treatments for glioma requires faithful in vivo disease …

Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation

S Xia, B Lal, B Tung, S Wang, CR Goodwin… - Neuro …, 2015 - academic.oup.com
Background Glioblastoma (GBM) is the most frequent and aggressive primary brain tumor in
adults. Recent research on cancer stroma indicates that the brain microenvironment plays a …

Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells

A Golebiewska, S Bougnaud, D Stieber, NHC Brons… - Brain, 2013 - academic.oup.com
The identification and significance of cancer stem-like cells in malignant gliomas remains
controversial. It has been proposed that cancer stem-like cells display increased drug …

Effect of cancer-associated fibroblasts on the migration of glioma cells in vitro

J Trylcova, P Busek, K Smetana, E Balaziova… - Tumor Biology, 2015 - Springer
Cancer-associated fibroblasts (CAFs) significantly influence biological properties of many
tumors. The role of these mesenchymal cells is also anticipated in human gliomas. To …

Mesenchymal stromal-like cells in the glioma microenvironment: what are these cells?

A Clavreul, P Menei - Cancers, 2020 - mdpi.com
Simple Summary We review here what is currently known about the role of mesenchymal
stromal-like cells, which complicate our understanding of the glioma microenvironment. We …

NFAT1 is highly expressed in, and regulates the invasion of, glioblastoma multiforme cells

X Tie, S Han, L Meng, Y Wang, A Wu - PLoS One, 2013 - journals.plos.org
Members of the nuclear factor of activated T cells (NFAT) family have been identified as
regulators of oncogenic transformation in several human malignancies. A prominent …

[HTML][HTML] Multifaceted CXC chemokine receptor 4 (CXCR4) inhibition interferes with anti–vascular endothelial growth factor therapy–induced glioma dissemination

JP Gagner, Y Sarfraz, V Ortenzi, FM Alotaibi… - The American journal of …, 2017 - Elsevier
Resistance to antiangiogenic therapy in glioblastoma (GBM) patients may involve hypoxia-
induced expression of CXC motif chemokine receptor 4 (CXCR4) on invading tumor cells …

Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas

RJ Atkins, J Dimou, L Paradiso, AP Morokoff… - Journal of Clinical …, 2012 - Elsevier
Gliomas are aggressive brain tumours that, despite advances in multimodal therapies,
continue to portend a dismal prognosis. Glioblastoma multiforme (GBM) represents the most …

Neural stem cells improve the delivery of oncolytic chimeric orthopoxvirus in a metastatic ovarian cancer model

M Hammad, YR Cornejo, J Batalla-Covello… - Molecular Therapy …, 2020 - cell.com
Oncolytic virotherapy represents a promising approach for treating recurrent and/or drug-
resistant ovarian cancer. However, its successful application in the clinic has been …